Free Trial

Voyager Therapeutics (VYGR) News Today

Voyager Therapeutics logo
$3.53 +0.04 (+1.15%)
As of 04/24/2025 04:00 PM Eastern
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.97
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Rating of "Buy" from Brokerages
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have received an average rating of "Buy" from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating
Voyager Therapeutics, Inc. stock logo
FY2026 Earnings Forecast for VYGR Issued By Leerink Partnrs
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Equities researchers at Leerink Partnrs dropped their FY2026 earnings per share (EPS) estimates for shares of Voyager Therapeutics in a report released on Wednesday, April 16th. Leerink Partnrs analyst L. Nsongo now expects that the company
Research Analysts Offer Predictions for VYGR FY2026 Earnings
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics (NASDAQ:VYGR) Receives "Buy" Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $30.00 price objective on shares of Voyager Therapeutics in a research report on Tuesday.
Voyager Therapeutics, Inc. stock logo
ADAR1 Capital Management LLC Acquires 86,158 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
ADAR1 Capital Management LLC increased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) by 212.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,792 shares of the company's stock
TD Cowen Keeps Their Buy Rating on Voyager Therapeutics (VYGR)
Voyager Therapeutics, Inc. stock logo
Raymond James Financial Inc. Takes Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Raymond James Financial Inc. acquired a new position in Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 131,505 shares of the company's stock, v
Voyager Therapeutics, Inc. stock logo
Insider Selling: Voyager Therapeutics, Inc. (NASDAQ:VYGR) CEO Sells 10,885 Shares of Stock
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) CEO Alfred Sandrock sold 10,885 shares of Voyager Therapeutics stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $3.43, for a total value of $37,335.55. Following the completion of the sale, the chief executive officer now directly owns 430,931 shares of the company's stock, valued at approximately $1,478,093.33. This trade represents a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Voyager Therapeutics, Inc. stock logo
Prudential Financial Inc. Sells 82,100 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Prudential Financial Inc. trimmed its holdings in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) by 19.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 330,300 shares of the company's stock after selling 82,100
Voyager Therapeutics announces new data from two preclinical programs
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Buy" from Analysts
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) has been given an average rating of "Buy" by the nine ratings firms that are covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation o
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics (NASDAQ:VYGR) Share Price Passes Below 50 Day Moving Average - Here's What Happened
Voyager Therapeutics (NASDAQ:VYGR) Shares Cross Below 50 Day Moving Average - Should You Sell?
Voyager Therapeutics, Inc. stock logo
HC Wainwright Brokers Boost Earnings Estimates for VYGR
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Equities researchers at HC Wainwright upped their Q1 2025 earnings per share (EPS) estimates for Voyager Therapeutics in a research note issued to investors on Thursday, March 13th. HC Wainwright analyst P. Trucchio now anticipates that the
Voyager Therapeutics, Inc. stock logo
Wedbush Equities Analysts Reduce Earnings Estimates for VYGR
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Equities research analysts at Wedbush decreased their Q1 2025 EPS estimates for Voyager Therapeutics in a research report issued on Wednesday, March 12th. Wedbush analyst Y. Zhong now expects that the company will earn ($0.37) per share for
Voyager Therapeutics, Inc. stock logo
Cantor Fitzgerald Issues Positive Outlook for VYGR Earnings
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for Voyager Therapeutics in a research report issued to clients and investors on Wednesday, March 12th. Cantor Fitzgerald analyst P. Stavropoulos now expects that t
Voyager Therapeutics, Inc. stock logo
Canaccord Genuity Group Issues Pessimistic Forecast for Voyager Therapeutics (NASDAQ:VYGR) Stock Price
Canaccord Genuity Group reduced their price objective on shares of Voyager Therapeutics from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday.
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics' (VYGR) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reissued a "buy" rating and set a $30.00 price objective on shares of Voyager Therapeutics in a research note on Thursday.
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics' (VYGR) Outperform Rating Reaffirmed at Wedbush
Wedbush reaffirmed an "outperform" rating on shares of Voyager Therapeutics in a research note on Wednesday.
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics' (VYGR) Overweight Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reiterated an "overweight" rating on shares of Voyager Therapeutics in a report on Wednesday.
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics (NASDAQ:VYGR) Releases Earnings Results, Misses Expectations By $0.24 EPS
Voyager Therapeutics (NASDAQ:VYGR - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.59) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.24). Voyager Therapeutics had a return on equity of 8.33% and a net margin of 15.80%.
Wells Fargo Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR)
Voyager Therapeutics reports Q4 EPS (59c), consensus (35c)
Voyager Therapeutics announces data from SAD trial of VY7523
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics' (VYGR) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued a "buy" rating and set a $30.00 price target on shares of Voyager Therapeutics in a report on Monday.
Voyager Therapeutics, Inc. stock logo
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of "Buy" by Brokerages
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have been assigned a consensus rating of "Buy" from the nine brokerages that are covering the stock, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and one has given a stro
Get Voyager Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter.

VYGR Media Mentions By Week

VYGR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VYGR
News Sentiment

0.15

0.72

Average
Medical
News Sentiment

VYGR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VYGR Articles
This Week

8

4

VYGR Articles
Average Week

Get Voyager Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VYGR) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners